Literature DB >> 18546622

Role of p53 and Rb in ovarian cancer.

David C Corney1, Andrea Flesken-Nikitin, Jinhyang Choi, Alexander Yu Nikitin.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18546622      PMCID： PMC2774127          DOI： 10.1007/978-0-387-68969-2_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  145 in total

1.  Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression.

Authors:  B E Weissman; P J Saxon; S R Pasquale; G R Jones; A G Geiser; E J Stanbridge
Journal:  Science       Date:  1987-04-10       Impact factor: 47.728

2.  Two-photon laser scanning fluorescence microscopy.

Authors:  W Denk; J H Strickler; W W Webb
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

3.  An analysis of abnormalities of the retinoblastoma gene in human ovarian and endometrial carcinoma.

Authors:  H Sasano; J Comerford; S G Silverberg; C T Garrett
Journal:  Cancer       Date:  1990-11-15       Impact factor: 6.860

4.  Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.

Authors:  Gad Singer; Robert Oldt; Yoram Cohen; Brant G Wang; David Sidransky; Robert J Kurman; Ie-Ming Shih
Journal:  J Natl Cancer Inst       Date:  2003-03-19       Impact factor: 13.506

5.  Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach.

Authors:  Akiko Horiuchi; Kazuko Itoh; Motohiko Shimizu; Ikuko Nakai; Teruyuki Yamazaki; Kaoru Kimura; Akihiko Suzuki; Isao Shiozawa; Noritane Ueda; Ikuo Konishi
Journal:  Gynecol Oncol       Date:  2003-03       Impact factor: 5.482

6.  Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.

Authors:  Denise C Connolly; Rudi Bao; Alexander Yu Nikitin; Kasie C Stephens; Timothy W Poole; Xiang Hua; Skye S Harris; Barbara C Vanderhyden; Thomas C Hamilton
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

7.  Sulindac causes regression of rectal polyps in familial adenomatous polyposis.

Authors:  D Labayle; D Fischer; P Vielh; F Drouhin; A Pariente; C Bories; O Duhamel; M Trousset; P Attali
Journal:  Gastroenterology       Date:  1991-09       Impact factor: 22.682

8.  Structural evidence for the authenticity of the human retinoblastoma gene.

Authors:  Y K Fung; A L Murphree; A T'Ang; J Qian; S H Hinrichs; W F Benedict
Journal:  Science       Date:  1987-06-26       Impact factor: 47.728

9.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence.

Authors:  W H Lee; R Bookstein; F Hong; L J Young; J Y Shew; E Y Lee
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

10.  An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma.

Authors:  V R Zurawski; R C Knapp; N Einhorn; P Kenemans; R Mortel; K Ohmi; R C Bast; R E Ritts; G Malkasian
Journal:  Gynecol Oncol       Date:  1988-05       Impact factor: 5.482
View more
  21 in total

Review 1.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

2.  MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF.

Authors:  Chang-Il Hwang; Jinhyang Choi; Zongxiang Zhou; Andrea Flesken-Nikitin; Alexander Tarakhovsky; Alexander Yu Nikitin
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

3.  Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer model.

Authors:  Lena J Gamble; Hideyo Ugai; Minghui Wang; Anton V Borovjagin; Qiana L Matthews
Journal:  J Mol Biochem       Date:  2012-02-15

Review 4.  MicroRNA and ovarian cancer.

Authors:  David C Corney; Alexander Yu Nikitin
Journal:  Histol Histopathol       Date:  2008-09       Impact factor: 2.303

Review 5.  Targeted immune therapy of ovarian cancer.

Authors:  Keith L Knutson; Lavakumar Karyampudi; Purushottam Lamichhane; Claudia Preston
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

6.  Frequent downregulation of miR-34 family in human ovarian cancers.

Authors:  David C Corney; Chang-Il Hwang; Andres Matoso; Markus Vogt; Andrea Flesken-Nikitin; Andrew K Godwin; Aparna A Kamat; Anil K Sood; Lora H Ellenson; Heiko Hermeking; Alexander Yu Nikitin
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

7.  Immunity and immune suppression in human ovarian cancer.

Authors:  Claudia C Preston; Ellen L Goode; Lynn C Hartmann; Kimberly R Kalli; Keith L Knutson
Journal:  Immunotherapy       Date:  2011-04       Impact factor: 4.196

8.  Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.

Authors:  Amir A Jazaeri; Jennifer L Bryant; Hong Park; Hui Li; Neetu Dahiya; Mark H Stoler; James Stuart Ferriss; Anindya Dutta
Journal:  Neoplasia       Date:  2011-10       Impact factor: 5.715

Review 9.  Evaluating the progenitor cells of ovarian cancer: analysis of current animal models.

Authors:  Shelby M King; Joanna E Burdette
Journal:  BMB Rep       Date:  2011-07       Impact factor: 4.778

10.  Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary.

Authors:  Dmitriy W Gutkin; Michael R Shurin; Mounia Alaoui El Azher; Galina V Shurin; Liudmila Velikokhatnaya; Denise Prosser; Namhee Shin; Francesmary Modugno; Paul Stemmer; Esther Elishaev; Anna Lokshin
Journal:  Cancer Biomark       Date:  2019       Impact factor: 4.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.